Investigation of Genetic Disease Marker Associated With Korean Glaucoma Patients
2 other identifiers
observational
1,224
1 country
1
Brief Summary
A single-nucleotide polymorphism (SNP) analysis of DNA obtained from peripheral blood of the glaucoma patients and the normal control will be performed to find genetic marker for primary open angle glaucoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2007
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 2, 2009
CompletedFirst Posted
Study publicly available on registry
December 3, 2009
CompletedDecember 3, 2009
December 1, 2009
2.8 years
December 2, 2009
December 2, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
genotyping for the SNP associated with primary open angle glaucoma
one year
Secondary Outcomes (1)
genotyping for rs7961953 and additional SNPs in TMTC2 from other linkage disequilibrium patterns
one year
Study Arms (2)
POAG group
Elevated intraocular pressure normal open angle glaucomatous optic nerve head abnormality glaucomatous visual field defect
Normal control
Normal intraocular pressure No optic disc abnormality No visual field defect No significant ocular and systemic disease
Interventions
SNP analysis of the DNA obtained from peripheral blood sample
Eligibility Criteria
patients with open angle glaucoma who visited glaocoma clinic of departemtn of Ophtalmology, Chungnam National University Hospital, Daejeon, south Korea
You may qualify if:
- Clinical diagnosis of primary open angle glaucoma
You may not qualify if:
- Primary open angle glaucoma combined with congenital ocular disease
- Primary open angel glaucoma combined with other ocular disease
- Significant systemic disease other than systemic hypertension and diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chungnam National University Hospital
Daejeon, 301-721, South Korea
Biospecimen
Peripheral blood sample
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chang-sik Kim, professor
Department of Ophthalmology, Chungnam National University Hospital
- STUDY CHAIR
Changwon Kang, professor
Korea Advanced Institute of Science and Technology
- STUDY DIRECTOR
Kyunglan Kim
Department of Biological Sciences, Korea Advanced Institute of Science and Technology
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 2, 2009
First Posted
December 3, 2009
Study Start
January 1, 2007
Primary Completion
October 1, 2009
Study Completion
November 1, 2009
Last Updated
December 3, 2009
Record last verified: 2009-12